December 04, 2016 7:03 PM ET


Company Overview of Affectis Pharmaceuticals AG

Company Overview

Affectis Pharmaceuticals AG, a pharmaceutical company, focuses on developing novel drugs for the treatment of neurodegenerative and neuroinflammatory diseases. The company’s products pipeline includes AFC-5128, an oral CNS-penetrant P2X7 antagonist for the treatment of neuropathic pain and multiple sclerosis; and AFC-08, a TMEFF2 monoclonal antibody for the treatment of depression. It was formerly known as Neuronova AG and changed its name to Affectis Pharmaceuticals AG in January 2005. The company was founded in 2004 and is based in Dortmund, Germany. As of January 7, 2014, Affectis Pharmaceuticals AG operates as a subsidiary of LDC Beteiligungen UG (haftungsbeschränkt).

Otto-Hahn-Straße 15

Dortmund,  44227


Founded in 2004


49 231 9742 7000


49 231 9742 7039

Key Executives for Affectis Pharmaceuticals AG

Chief Executive Officer
Co-Founder and Member of Supervisory Board
Founder and Member of the Scientific Advisory Board
Chief Medical Officer
Age: 53
Director of Behavioural Pharmacology
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
3B Pharmaceuticals GmbH Europe
Accelsiors Group International Europe
Aenova Group GmbH Europe
Aenova Holding GmbH Europe
AiCuris GmbH & Co. KG Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Affectis Pharmaceuticals AG, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at